Return to homepagePandemic Pact

Enhancing mRNA vaccines by exploiting pathways of antigen presentation

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA409708

Grant search

Key facts

  • Disease

    N/A

  • Start & end year

    2025
    2028

  • Known Financial Commitments (USD)

    $438,134.07

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Principal Investigator

    N/A

  • Research Location

    Australia

  • Lead Research Institution

    University of Melbourne

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

mRNA-LNP vaccines, such as those used to prevent COVID-19 infection, are an exciting new frontier in vaccination. Currently, they are limited by their ability to elicit short-lived immune responses and, in some individuals, elicit adverse events. Here, we will investigate new innovations to improve the immunogenic outcomes and safety profile of mRNA-LNP vaccines.